MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease

    L. Collins-Praino, A. Mcnamara, B. Ellul, I. Baetu, S. Lau, M. Jenkinson (Adelaide, Australia)

    Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…
  • 2024 International Congress

    Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

    MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)

    Objective: To verify whether connectivity changes in the dorsolateral prefrontal cortex (DLPC) and the precuneus (PCun) can predict cognitive phenotypes in de novo Parkinson’s disease…
  • 2024 International Congress

    Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

    SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

    Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…
  • 2024 International Congress

    Apathy produces selective deficits in cognitive function when controlling for depression in patients with Parkinson’s disease

    G. Badwal, K. Patel, S. Pasternak, H. Ganjavi, R. Renwick, R. Camicioli, K. van Hedger, P. Macdonald (London, Canada)

    Objective: To compare differences in the mean cognitive impairment (CI) of patients with and without clinically significant apathy in PD, PD-mild cognitive impairment (PD-MCI), and…
  • 2024 International Congress

    Parkinson’s Disease (PD) and predictors of Driving Cessation: Results from a 6-year Longitudinal Study and a systematic review of the literature

    P. Stamatelos, P. Hatzaki, I. Beratis, D. Pavlou, N. Andronas, E. Stanitsa, S. Fragkiadaki, D. Kontaxopoulou, A. Bonakis, A. Economou, G. Yannis, L. Stefanis, S. Papageorgiou (Athens, Greece)

    Objective: We sought to identify predictors of driving cessation among PD patients. Background: Motor and cognitive impairment of PD patients interfere with their driving ability.…
  • 2024 International Congress

    The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

    A. Rosal, A. Strafella, S. Martin (Toronto, Canada)

    Objective: To assess the contribution of Apolipoprotein E4 (APOE4) in Parkinson’s Disease (PD)-related cognitive impairment by analyzing its impact on Gray Matter Volume (GMV). Background:…
  • 2024 International Congress

    Longitudinal Relationship Between Brain Metabolism and Clinical Changes in Huntington’s Disease

    A. Gravier, S. Lavisse, R. Massart, A. Gil-Salcedo, P. Lemercier, O. Barret, V. Gaura, AC. Bachoud-Levi, P. Remy (Créteil, France)

    Objective: To understand the relationship between progression of the clinical symptoms and patterns of brain hypometabolism progression in a large cohort of Huntington’s disease (HD)…
  • 2024 International Congress

    Early-onset Parkinsonism as Presenting Manifestation of CADASIL in a Mexican Woman with NOTCH3 c.1732C>T Pathogenic Variant

    M. Arbeu Reyes, B. Madariaga Cortés, S. Castillo Torres (Puebla, Mexico)

    Objective: To report the case of a patient with parkinsonism as initial symptom, secondary to an specific NOTCH3 pathogenic variant.Objective: To report the case of…
  • 2024 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

    T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: The aim of this study is to evaluate the prevalence of CI in a diverse group of PwP from East London, UK and Dhaka,…
  • 2024 International Congress

    Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Activities of Daily Living, Behavioural and Cognitive ability (A-B-C) of PD Patients: A Randomized Controlled Trial

    R. Makkar, R. Hazrati, A. Nehra (Ghaziabad, India)

    Objective: The aim of the RCT was to study the effectiveness of rTMS on the activities of daily living, behavioural and cognitive ability (A-B-C) of…
  • 1
  • 2
  • 3
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley